CPSF4 and metabolic dysfunction-associated steatotic liver disease: In conclusion, NARI and NAR have shown promising therapeutic potential in preclinical studies in the context of MASLD, attributable to their antioxidant, anti-inflammatory, and lipid metabolism-modulating properties.